Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice

Yan Cai; Mitsuhiro Yoneda; Takeshi Tomita; Reiko Kurotani; Minoru Okamoto; Taketomo Kido; Hiroyuki Abe; Mitzner, Wayne; Guha, Arjun; Shioko Kimura
July 2015
BMC Pulmonary Medicine;Jul2015, Vol. 15 Issue 1, p1
Academic Journal
Background: Secretoglobin (SCGB) 3A2, a cytokine-like secretory protein of small molecular weight, is predominantly expressed in airway epithelial cells. While SCGB3A2 is known to have anti-inflammatory, growth factor, and anti-fibrotic activities, whether SCGB3A2 has any other roles, particularly in lung homeostasis and disease has not been demonstrated in vivo. The aim of this study was to address these questions in mice. Methods: A transgenic mouse line that expresses SCGB3A2 in the lung using the human surfactant protein-C promoter was established. Detailed histological, immunohistochemical, physiological, and molecular characterization of the Scgb3a2-transgenic mouse lungs were carried out. Scgb3a2-transgenic and wild-type mice were subjected to bleomycin-induced pulmonary fibrosis model, and their lungs and bronchoalveolar lavage fluids were collected at various time points during 9 weeks post-bleomycin treatment for further analysis. Results: Adult Scgb3a2-transgenic mouse lungs expressed approximately five-fold higher levels of SCGB3A2 protein in comparison to wild-type mice as determined by western blotting of lung tissues. Immunohistochemistry showed that expression was localized to alveolar type II cells in addition to airway epithelial cells, thus accurately reflecting the site of surfactant protein-C expression. Scgb3a2-transgenic mice showed normal lung development and histology, and no overt gross phenotypes. However, when subjected to a bleomycin-induced pulmonary fibrosis model, they initially exhibited exacerbated fibrosis at 3 weeks post-bleomycin administration that was more rapidly resolved by 6 weeks as compared with wild-type mice, as determined by lung histology, Masson Trichrome staining and hydroxyproline content, inflammatory cell numbers, expression of collagen genes, and proinflammatory cytokine levels. The decrease of fibrosis coincided with the increased expression of SCGB3A2 in Scgb3a2-transgenic lungs. Conclusions: These results demonstrate that SCGB3A2 is an anti-fibrotic agent, and suggest a possible therapeutic use of recombinant SCGB3A2 in the treatment of pulmonary fibrosis.


Related Articles

  • Epithelial cell α3β 1 integrin links β-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. Kim, Kevin K.; Ying Wei; Szekeres, Charles; Kugler, Matthias O.; Wolters, Paul J.; Hill, Maria L.; Frank, James A.; Brumwell, Alexis N.; Wheeler, Sarah E.; Kreidberg, Jordan A.; Chapman, Harold A. // Journal of Clinical Investigation;Jan2009, Vol. 119 Issue 1, p213 

    Pulmonary fibrosis, in particular idiopathic pulmonary fibrosis (IPF), results from aberrant wound healing and scarification. One population of fibroblasts involved in the fibrotic process is thought to originate from lung epithelial cells via epithelial-mesenchymal transition (EMT). Endeed,...

  • KCa3.1 K+ Channel Expression and Function in Human Bronchial Epithelial Cells. Arthur, Greer K.; Duffy, S. Mark; Roach, Katy M.; Hirst, Rob A.; Shikotra, Aarti; Gaillard, Erol A.; Bradding, Peter // PLoS ONE;12/21/2015, Vol. 10 Issue 12, p1 

    The KCa3.1 K+ channel has been proposed as a novel target for pulmonary diseases such as asthma and pulmonary fibrosis. It is expressed in epithelia but its expression and function in primary human bronchial epithelial cells (HBECs) has not been described. Due to its proposed roles in the...

  • The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium. Seibold, Max A.; Smith, Russell W.; Urbanek, Cydney; Groshong, Steve D.; Cosgrove, Gregory P.; Brown, Kevin K.; Schwarz, Marvin I.; Schwartz, David A.; Reynolds, Susan D. // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    Background: We previously identified a MUC5B gene promoter-variant that is a risk allele for sporadic and familial Idiopathic Pulmonary Fibrosis/Usual Interstitial Pneumonia (IPF/UIP). This allele was strongly associated with increased MUC5B gene expression in lung tissue from unaffected...

  • HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53. Klein, Andreas; Guhl, Eva; Tzeng, Yin-Jeh; Fuhrhop, Jutta; Levrero, Massimo; Graessmann, Monika; Graessmann, Adolf // Oncogene;5/15/2003, Vol. 22 Issue 19, p2910 

    Transgenic mice, which selectively express the WAP-HBX transgene in mammary gland epithelial cells (ME-cells), were established in order to elucidate the consequences of HBX gene expression on organ differentiation, cell death program and tumor development. Transgene expression was demonstrable...

  • Role of MMP-2 in Alveolar Epithelial Cell Repair after Bleomycin Administration in Rabbits. Kunugi, Shinobu; Fukuda, Yuh; Ishizaki, Masamichi; Yamanaka, Nobuaki // Laboratory Investigation (00236837);Sep2001, Vol. 81 Issue 9, p1309 

    Matrix metalloproteinases (MMPs) have been implicated in the pathological processes of interstitial lung diseases. However, underlying mechanisms, particularly for activity levels and distribution of activated MMP-2 in the disease process, are yet to be elucidated. The present study investigated...

  • Resistin-like molecule alpha1 (Fizz1) recruits lung dendritic cells without causing pulmonary fibrosis. Madala, Satish K.; Edukulla, Ramakrishna; Davis, Katy R.; Schmidt, Stephanie; Davidson, Cynthia; Kitzmiller, Joseph A.; Hardie, William D.; Korfhagen, Thomas R. // Respiratory Research;Jun2012, Vol. 13 Issue 6, p1 

    Background: Resistin-like molecule alpha or found in inflammatory zone protein (Fizz1) is increased in pulmonary epithelial cells and also in limited amounts by other lung cells during various lung injuries and fibrosis. However, the direct role of Fizz1 produced in the pulmonary epithelium has...

  • Murine candidate bleomycin induced pulmonary fibrosis susceptibility genes identified by gene expression and sequence analysis of linkage regions. Haston, C. K.; Tomko, T. G.; Godin, N.; Kerckhoff, L.; Hallett, M. T. // Journal of Medical Genetics;Jun2005, Vol. 42 Issue 6, p464 

    Background: Pulmonary fibrosis is a complex disease for which the predisposing genetic variants remain unknown. In a prior study, susceptibility to bleomycin induced pulmonary fibrosis was mapped to loci Blmpf1 and Blmpf2 on chromosomes 17 and 11, respectively, in a C57BL/6J (B6, susceptible)...

  • Luciferase expression is driven by the promoter of fibroblast activation protein-α in murine pulmonary fibrosis. Wenlong, Li; Leilei, Yang; Wei, Fan; Yi, Chen; Jing, Tian; Lanzhi, Ma; Bing, Liu; Yang, Li; Shaoxia, Wang; Qiuxia, Fu; Zeliang, Chen; Zengming, Zhao // Biotechnology Letters;Sep2015, Vol. 37 Issue 9, p1757 

    Objectives: We used optical imaging of live animals and transgenic technology to develop a pulmonary fibrosis model in mice that can non-invasively and in real-time trace the pulmonary fibrosis process. Results: Fibroblast activation protein-α (FAPα) is selectively expressed in fibrotic...

  • Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways. Sumner-Jones, S. G.; Davies, L. A.; Varathalingam, A.; Gill, D. R.; Hyde, S. C. // Gene Therapy;Dec2006, Vol. 13 Issue 24, p1703 

    Recombinant adeno-associated virus vectors based on serotype 2 (rAAV2) have been used to deliver transgenes to the airways in a variety of pre-clinical and clinical studies. Gene transfer in these studies has been severely restricted by the basolateral localization of rAAV2 receptors. Here, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics